Zepbound 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FQ81N
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,971
Award facts
- Contract value 100% obligated
- $28,970.79 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 19, 2025, by the Defense Logistics Agency for $28,970.79 to supply Zepbound (semaglutide) 7.5 mg/0.5 mL pens. The award is classified as a firm fixed-price delivery order with an ultimate completion date of September 22, 2025, and represents a non-competitive award. This contract award is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a global pharmaceutical support vehicle for military healthcare systems.
The delivery order falls within AmerisourceBergen's extensive federal contract portfolio with the Defense Logistics Agency's Medical Supply Chain, which encompasses a comprehensive range of pharmaceutical products and medical supplies serving military and veteran healthcare systems. The company's demonstrated capability to fulfill such orders through competitive federal procurement, combined with its role as a critical vendor through the DLA Troop Support Medical prime vendor contract, enables efficient fulfillment of pharmaceutical needs across the Defense Health Agency and other federal healthcare systems. The performance location is listed as Conshohocken, Pennsylvania, the company's corporate headquarters.
Quick answers
Who was awarded contract SPE2DB25FQ81N?
SPE2DB25FQ81N was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 19, 2025.
How much is contract SPE2DB25FQ81N worth?
The government has obligated $28,971 on SPE2DB25FQ81N.
Is contract SPE2DB25FQ81N an order under another contract?
Yes. SPE2DB25FQ81N is a delivery order under SPE2DB22D3004, an indefinite delivery contract.
Was contract SPE2DB25FQ81N competed?
The extent of competition for SPE2DB25FQ81N was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award